Instil Bio Inc (TIL)
11.58
+0.35
(+3.12%)
USD |
NASDAQ |
May 10, 16:00
11.22
-0.36
(-3.11%)
After-Hours: 20:00
Instil Bio Shareholders Equity (Quarterly): 225.83M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 225.83M |
| September 30, 2023 | 234.02M |
| June 30, 2023 | 296.52M |
| March 31, 2023 | 311.15M |
| December 31, 2022 | 363.60M |
| September 30, 2022 | 410.59M |
| June 30, 2022 | 458.33M |
| Date | Value |
|---|---|
| March 31, 2022 | 508.56M |
| December 31, 2021 | 555.20M |
| September 30, 2021 | 601.42M |
| June 30, 2021 | 635.47M |
| March 31, 2021 | 665.15M |
| December 31, 2020 | -39.60M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-39.60M
Minimum
Dec 2020
665.15M
Maximum
Mar 2021
402.02M
Average
410.59M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 325.63M |
| Total Liabilities (Quarterly) | 99.80M |